Page last updated: 2024-12-07
eth 1001
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
ETH 1001: Ca++ carrier; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 14009349 |
SCHEMBL ID | 678280 |
MeSH ID | M0132916 |
Synonyms (17)
Synonym |
---|
eth 1001 |
58801-34-6 |
calcium ionophore |
calcium ionophore i |
AKOS015896894 |
SCHEMBL678280 |
CA-1001 , |
calcium ionophore i, selectophore(tm), function tested, >=99.0% |
calcium-ionophore i |
(17r,18r)-diethyl 13,17,18,22-tetramethyl-14,21-dioxo-16,19-dioxa-13,22-diazatetratriacontane-1,34-dioate |
D96064 |
AS-56050 |
5-(4-ethoxy-phenyl)-2h-pyrazole-3-carboxylicacid |
EX-A6685 |
CS-0129640 |
HY-136460 |
diethyl (17r,18r)-13,17,18,22-tetramethyl-14,21-dioxo-16,19-dioxa-13,22-diazatetratriacontanedioate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |